| 1 |
Johnston JN, Kadriu B, Allen J, Gilbert JR, Henter ID, Zarate CA Jr. Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment. Neuropharmacology 2023;226:109422. [PMID: 36646310 DOI: 10.1016/j.neuropharm.2023.109422] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Meccia J, Lopez J, Bagot RC. Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms. Psychopharmacology (Berl) 2023;240:27-40. [PMID: 36564671 DOI: 10.1007/s00213-022-06297-0] [Reference Citation Analysis]
|
| 3 |
Arnsten AFT, Joyce MKP, Roberts AC. The Aversive Lens: Stress effects on the prefrontal-cingulate cortical pathways that regulate emotion. Neurosci Biobehav Rev 2023;145:105000. [PMID: 36529312 DOI: 10.1016/j.neubiorev.2022.105000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, Wolf G, Lerer B, Lifschytz T. Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. Int J Mol Sci 2022;23. [PMID: 36430623 DOI: 10.3390/ijms232214148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, Deboer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH. Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. ACS Pharmacol Transl Sci 2022. [DOI: 10.1021/acsptsci.2c00177] [Reference Citation Analysis]
|
| 6 |
Goel DB, Zilate S. Potential Therapeutic Effects of Psilocybin: A Systematic Review. Cureus 2022;14:e30214. [PMID: 36381758 DOI: 10.7759/cureus.30214] [Reference Citation Analysis]
|
| 7 |
Schmitz GP, Jain MK, Slocum ST, Roth BL. 5-HT(2A) SNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics. ACS Chem Neurosci 2022;13:2386-98. [PMID: 35894503 DOI: 10.1021/acschemneuro.1c00815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Shahar O, Botvinnik A, Esh-zuntz N, Brownstien M, Wolf R, Wolf G, Lerer B, Lifschytz T. Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications.. [DOI: 10.1101/2022.07.22.501026] [Reference Citation Analysis]
|
| 9 |
Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. New Paradigms of Old Psychedelics in Schizophrenia. Pharmaceuticals (Basel) 2022;15:640. [PMID: 35631466 DOI: 10.3390/ph15050640] [Reference Citation Analysis]
|
| 10 |
Olson DE. Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity. Biochemistry 2022;61:127-36. [PMID: 35060714 DOI: 10.1021/acs.biochem.1c00812] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 11 |
Desouza LA, Benekareddy M, Fanibunda SE, Mohammad F, Janakiraman B, Ghai U, Gur T, Blendy JA, Vaidya VA. The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex. Front Mol Neurosci 2021;14:790213. [PMID: 35002622 DOI: 10.3389/fnmol.2021.790213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Schmitz GP, Jain MK, Slocum ST, Roth BL. Pharmacologic analysis of non-synonymous coding 5-HT2A SNPs reveals alterations psychedelic drug potencies and efficacies.. [DOI: 10.1101/2021.12.09.472000] [Reference Citation Analysis]
|
